|
Information was received from multiple sources regarding a patient implanted with a neurostimulator (ins).Lead migration/dislodgement and inadequate pain relief was reported.It was reported that the scs is not helpful and has been turned off.Met with a manufacture representative on 4/14/26 and was told that there were issues with their leads.Unable to do lead revision due to afib and recent placement of pacemaker.Patient reported that as far as they know, the device is not working even if they charge it.It charges and functions but it doesn't provide the therapy they need.Patient has not had the device checked out by the hcp for a while and do not plan to deal with the device as they had other unrelated health issues that they need a surgery for; patient confirmed the surgery was unrelated.Patient was asked about the lead issues and patient said they just told them that leads were not working.Patient doesn¿t remember if there was a manufacturer rep present there or not.This was about a year ago.Patient said the hcp has always been the same as the one who implanted the device but patient doesn¿t remember the name.Patient said as far as they remember, no one mentioned lead migration to them, they just said the lead was not working.Rep reported that the cause of lead issue/migration was unknown.Hcp will do a lead revision one the patient is able to hold her blood thinners for the procedure.Clinic will look into the guidelines from her cardiologist on how long she needs to remain on the blood thinners after her pacemaker implant.
|
|
Continuation of d10: product id 977a260 lot# serial# (b)(6) implanted: (b)(6) 2023 product type lead product id 977a260 lot# serial# (b)(6) implanted: (b)(6) 2023 product type lead section d information references the main component of the system.Other relevant device(s) are: product id: 977a260, serial/lot #: (b)(6), ubd: 10-nov-2026, udi#: (b)(4) ; product id: 977a260, serial/lot #: (b)(6), ubd: 21-nov-2026, udi#: (b)(4) medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|